The landscape of pancreatic cancer therapeutic resistance mechanisms

Authors

Saswati N. Chand, Department of Surgery, The Jefferson Pancreas, Biliary, and Related Cancer Center, Thomas Jefferson UniversityFollow
Kevin O’Hayer, Department of Surgery, The Jefferson Pancreas, Biliary, and Related Cancer Center, Thomas Jefferson University; Department of Medical Oncology, Thomas Jefferson University; Department of Pharmacology and Experimental Therapeutics, Division of Clinical Pharmacology, Thomas Jefferson University
Fernando F. Blanco, Department of Surgery, The Jefferson Pancreas, Biliary, and Related Cancer Center, Thomas Jefferson University; Department of Pharmacology and Experimental Therapeutics, Division of Clinical Pharmacology, Thomas Jefferson UniversityFollow
Jordan M Winter, Department of Surgery, The Jefferson Pancreas, Biliary, and Related Cancer Center, Thomas Jefferson UniversityFollow
Jonathan Brody, MD, Department of Surgery, The Jefferson Pancreas, Biliary, and Related Cancer Center, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

1-27-2016

Comments

This article has been peer reviewed. It was published in: International Journal of Biological Sciences.

Volume 12, Issue 3, 27 January 2016, Pages 273-283.

The published version is available at DOI: 10.7150/ijbs.14951

Copyright © 2016 Ivyspring International Publisher

Recommended Citation

Chand, Saswati N.; O’Hayer, Kevin; Blanco, Fernando F.; Winter, Jordan M; and Brody, MD, Jonathan, "The landscape of pancreatic cancer therapeutic resistance mechanisms" (2016). Department of Pharmacology and Experimental Therapeutics Faculty Papers. Paper 66.
https://jdc.jefferson.edu/petfp/66